Tizanidine
Product Images NDC 45865-386

4 FDA label images from Medsource Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 45865-386). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Tizanidine 2mg 1)

Structure (Tizanidine 2mg 1)
Chemical structure of Tizanidine hydrochloride, showing its molecular framework with nitrogen and chlorine atoms. The diagram illustrates the arrangement of the bicyclic and imidazoline rings typical of the active ingredient.*
FDA Label Image

Fig1 (Tizanidine 2mg 2)

Fig1 (Tizanidine 2mg 2)
A line graph depicting improvement in Ashworth Score over time (hours post-dose) for 16 mg tizanidine, 8 mg tizanidine, and placebo. The y-axis shows improvement scores, and the x-axis shows hours post-dose from 0 to 6. The 16 mg dose shows the greatest improvement, followed by 8 mg, with placebo showing minimal change.*
FDA Label Image

Fig2 (Tizanidine 2mg 3)

Fig2 (Tizanidine 2mg 3)
A line graph showing improvement in Ashworth Score over time at three points: End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward). It compares outcomes for Tizanidine with a mean dose of 28.8 mg and placebo, indicating greater improvement with Tizanidine at each time point with error bars.*
FDA Label Image

Bottle Of 30 (Tizanidine 2mg 4)

Bottle Of 30 (Tizanidine 2mg 4)
Label for Tizanidine HCL Tablets 2 mg, generic for Zanaflex, from Medsource Pharmaceuticals. The label indicates a quantity of 30 tablets, describes the tablets as white and oval with imprint R179, and includes warnings about dizziness and drowsiness. The label displays lot and manufacturing details with instructions to take tablets daily.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.